Oak Harbor Wealth Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Oak Harbor Wealth Partners's PFE Position: Q1 2026 in Review
Oak Harbor Wealth Partners increased its Pfizer (PFE) stake by 3% in Q1 2026, buying an estimated $52.2K and bringing the position to 66,986 shares worth $1.88M. The position accounts for 0.44% of the portfolio, ranked #61.
Oak Harbor Wealth Partners first reported a position in PFE in Q4 2021 and has held it in 18 quarters since. The position peaked at $4.15M in Q4 2021. 2,935 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Oak Harbor Wealth Partners held 66,986 shares of Pfizer worth $1.88M as of Q1 2026.
- Oak Harbor Wealth Partners bought 1,960 Pfizer shares in Q1 2026, an estimated $52.2K.
- Pfizer made up 0.44% of Oak Harbor Wealth Partners's portfolio in Q1 2026, its #61 holding.
- Oak Harbor Wealth Partners first reported a position in Pfizer in Q4 2021 and has held it in 18 quarters since.
- Oak Harbor Wealth Partners's Pfizer position peaked at $4.15M in Q4 2021.
- 2,935 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Oak Harbor Wealth Partners's 13F filing for Q1 2026, filed 7 May 2026.